The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...
Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.
Introduction Atrial fibrillation (AF) is the leading cause of cardioembolic stroke and is associated with increased stroke severity and fatality. Early identification of AF is essential for adequate ...
When the flu strikes, it can feel relentless: rising fever, hacking cough, stuffy nose and sore throat. For many people, relief can come in the form of Tamiflu, a prescription antiviral medication ...
Q At age 51, I was diagnosed with severe rheumatic mitral stenosis. After a second round of tests, treatment was changed from ...
First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...
In clinical practice guidelines issued by the American College of Cardiology and American Heart Association and published ...
News-Medical.Net on MSN
ARB drugs lead to better blood pressure treatment adherence
Patients who start their blood pressure treatment with ARB drugs continue with the same medicine to a greater extent than ...
The FDA has approved Myqorzo for the treatment of adults with symptomatic oHCM to improve functional capacity and symptoms.
Aortic stenosis is a narrowing of the aortic valve which connects the heart to the rest of the body. It affects millions of people and can be fatal if left untreated. At present, there are no ...
HORSHAM, PA — Johnson & Johnson (NYSE: JNJ) has won U.S. Food and Drug Administration approval for RYBREVANT FASPRO, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback